-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In addition to their pro-inflammatory effects, eosinophils also have antiviral properties
COVID-19
The researchers analyzed data from the Cleveland Clinic COVID-19 Research Registry (April 1, 2020 to March 31, 2021)
Of the 46,397 patients included in the final analysis, 19,506 patients had pre-existing eosinophilia (>0.
Among iCS-treated patients, adjusted analysis found eosinophilia associated with hospitalization (OR [95%CI]: 0.
Thus, the association between eosinophilia and improved outcomes in COVID-19 patients depends on iCS
The association between eosinophilia and improved outcomes in COVID-19 patients depends on iCS
Original source:
Joe G.
Eosinophilia is associated with improved COVID-19 outcomes in inhaled corticosteroids-treated
patients